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Background. Cardiac insufficiency is one of the main causes of morbidity and mortality in the world. 
Objective. The aim of the study was to determine the content of interleukins in male rats with adrenaline-
calcium model of myocardial injury (ACM) and under correction by quercetin.
Methods. 143 Wistar male-rats aged 5-6 months were used in the experiments. The changes of interleukins 
(IL-1beta, IL-2, IL-4, IL-6, IL-10, TNF-alpha) content in blood serum in the development of heart injury by adrenaline 
and calcium (AC) and use of quercetin for protection were studied. The period of investigation was in 1, 2, 24 
hours, 3, 7, 14, 21, 28 days.
Results. In ACM model of myocardial injury TNF-alpha increased, IL-2, IL-4 decreased at each period of 
investigation. IL-1beta increased in 2 and 3 days after the injury, at all other periods (except in 1 hour and 21 
days) those indices were decreased. Also we observed similar wave changes of IL-6 and IL-10 content.
Injections of quercetin for 7 days caused a significant decrease of IL-2, IL-4, IL-10, and increase of IL-6. In 7 
days of quercetin administration after AC-injury, decreased TNF-alpha was observed as well as increased IL-4, 
IL-6, and IL-1beta rates. In 14 days, the increase of TNF-alpha, normalization of IL-10 to control was evidenced. 
In 28 days, increased activation of IL-1beta, decreased content of TNF-alpha was fixed.
Conclusions. The development of adrenaline-calcium heart damage is accompanied by bright cytokine 
wavelike reaction at different time points. Quercetin causes normalization of interleukins level.
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Introduction
Cardiac insufficiency is one of the main 
causes of morbidity and mortality in the world. 
One of the causes of its development is 
myocardial infarction, when cardiomyocytes die 
due to prolonged ischemia. Myocardial in-
farction is a dynamic process, which is accom-
panied by transition of reversible changes to 
irreversible ischemic damage and completes in 
replacement of the diminished part of myo-
cardium by a fibrous scar. Development of 
fibrosis is a dysfunctional process in which 
myofibroblasts, the main fibrous cellular 
elements, are metabolically active and are able 
to produce and upregulate cytokines; they also 
have contractile properties [1]. Myocardial 
infarction leads to rapid necrosis of cardiac 
myocytes. To achieve tissue integrity and func-
tion, inflammatory cells are activated, including 
monocytes/macrophages. Impaired monocyte/
macrophage function is a not established new 
pathophysiological mechanism for left ven-
tricular thrombus development after myocardial 
infarction [2]. Myocardial damage in myocardial 
infarction takes place mainly due to ischemic 
necrosis and inflammatory mechanisms while 
apoptosis is the main mechanism of cell death 
in ‘reperfusion injury’ in addition to limited 
ischemic necrosis [3].
In the diseased heart, cardiomyocytes are 
lost to necrotic cell death, and phenotypically 
transformed fibroblast-like cells, termed ‘myo-
fibroblasts’, are activated to initiate a ‘reparative’ 
fibrosis. the structural integrity of myocardium 
is preserved by this scar tissue, although the 
expense of its remodeled structure, which in-
creases tissue stiffness and propensity to 
arrhythmias. A persisting population of acti-
vated myofibroblasts turns this fibrous tissue 
into a living ‘secretome’ that generates angio_
tensin ii and its type 1 receptor, fibrogenic 
growth factors, all of which collectively act as a 
signal-transducer-effector signaling pathway 
to type I collagen synthesis and, therefore, 
fibrosis. Persistent myofibroblasts, and the 
resultant fibrous tissue they produce, cause 
progressive adverse myocardial remodeling, a 
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Table 1. Division of animals by groups
Group
Quantity of animals
Total Mortality
Control 10 –
in 1 hour after АCМ 10 –
in 2 hours after АCМ 10 –
in 24 hours after АCМ 10 –
in 3 days after АCМ 10 –
in 7 days after АCМ 10 –
in 14 days after АCМ 10 –
in 21 days after АCМ 10 –
in 28 days after АCМ 12 16.67 %
Quercetin 10 –
in 7 days after АCМ + quercetin 10 –
in 14 days after АCМ + quercetin 10 –
in 21 days after АCМ + quercetin 10 –
in 28 days after АCМ + quercetin 11 8.33 %
pathological hallmark of the failing heart 
irrespective of its etiologic origin [4].
Cardiomyocyte necrosis activates an inflam­
matory response that serves to clear the injured 
myocardium from dead cells, and stimulates 
repair, but may also extend injury. Recently the 
studies in the literature have identified inter­ 
leukin­1a and RNA released by necrotic cardio­ 
myocytes as key danger signals that trigger the 
inflammatory response following infarction. 
Interleukin­1 promotes activation of a proinflam­
matory phenotype in leukocytes and fibroblasts, 
and delays myofibroblast transdifferentiation. 
Inhibitory lymphocytes are crucial in negative 
regulation of postinfarction inflammatory res­
ponse by modulating macrophage and fibroblast 
phenotype. Cardiac macrophages exhibit signifi­
cant heterogeneity and phenotypic plasticity and 
may manage the reparative response following 
infarction. In adult mice­ animals replacement 
of resident macrophage populations with mono­
cyte­derived macrophages may induce inflam­
mation while inhibiting cardiac regeneration [5].
Taking into account that the main pathogenic 
links are the development of inflammation, 
oxidative and nitric explosion, spasm of coronary 
vessels, necrosis, fibrosis, the study of the effec­
tiveness of cardioprotective activities for the 
treatment of the basic pathogenesis is necessary. 
These medications include quercetin, which has 
antioxidant, anti­spasm, anti­inflammatory, anti­
sclerotic properties [6].
Therefore, the aim of our study was to deter­
mine the content of interleukins in male rats with 
adrenalin­calcium model of myocardial injury 
(ACM) and to correct the pathological process 
by quercetin.
Methods
The experiments were performed on 143 
albino Wistar male rats 5­6 months of age. The 
animals were divided into 14 groups (Table 1). 
Each group comprised 10 animals. The rats 
were once intramuscularly administered with 
a 0.18% solution of adrenaline hydrotartrate at 
a dose of 0.5 mg/kg of body weight (Pharma­
ceutical firm “Darnitsa”, Ukraine) and intrape­ 
ritoneally with 5% solution of calcium gluconate 
(“Dniprofarm”, Ukraine) at a dose of 1 ml/100 g 
of body weight. For the correction the solution 
of quercetin at a dose of 200 mg/kg of body 
weight was injected intraperitoneally once a 
day for 7 days after adrenaline and calcium 
injections.
Experiments were performed in a special 
room in the morning at 18­22 °С, relative 
humidity 40­60% and illumination 250 lux. The 
regula tions of the European Convention for the 
Pro tec tion of Vertebrate Animals Used for Expe­
ri mental and Other Scientific Purposes (Stras­
bourg, 1986), Resolution of the First National 
Congress on Bioethics (Kyiv, 2001) and the 
Order of the Ministry of Health of Ukraine 
№ 690 dated September 23, 2009, were strictly 
followed.
The rats were euthanized by total heart 
bloodletting and previous thiopental sodium 
anesthesia (60 mg·kg­1 of body weight intra­
peritoneally). Blood samples were taken for the 
research. Concentration of interleukins IL­1beta, 
IL­2, IL­4, IL­6, IL­10, tumor necrosis factor alpha 
(TNF­alpha) was determined in blood serum by 
the method of immunoenzyme analysis using 
a set of reagents produced by ZAO vector­Best 
(Russia).
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A statistical analysis of digital data was 
performed by means of Excel (Microsoft, USA) 
and STATISTICA 6.0 (Statsoft, USA). Statistical 
significance of the differences between inde­
pendent indices was estimated by Student t­test 
at normal distribution and by nonparametric 
methods in other cases.
Results
In 1 hour after adrenaline and calcium 
injection, the increase of TNF­alpha in 7.56 
times (p<0.001), decrease of IL­4 by 35.63% 
(p<0.001) and of H­10 by 46.08% (p<0.001) were 
determined (Table 2).
In 2 hours IL-1 beta was increased by 
45.69 % (p<0.001) and TNF­alpha – in 5.9 times 
(p<0.001); IL­2 was decreased by 18.24% 
(p<0.002) and IL­6 – by 48.57% (p<0.001). The 
increase of IL­1 beta by 45.82% (p<0.01), of IL­10 
in 2.1 times (p<0.001), the decrease of IL­6 by 
47.55% (p<0.001) were determined compared 
with the previous study.
In 1 day, compared to the control, there was 
a decrease of IL­1beta by 38.58% (p<0.001), 
IL­2 – by 30.40% (p<0.001), IL­4 – by 23.45% 
(p<0.001), and increase of IL­6 in 46.68% 
(p<0.01), TNF­alpha – in 5.21 times (p<0.001), 
and compared to the previous study, there was 
a decrease of IL­1beta by 57.84% (p<0.001), 
IL­2 – by 14.88% (p<0.01), IL­10 – by 23.37% 
(p<0.01), increase of IL­6 in 2.85 times (p<0.001).
In 3 days, compared to the control, the level 
of IL­1beta was higher by 21.94% (p<0.001), 
TNF­alpha – in 7.06 times (p<0.01), IL­10 – by 
37.16% (p<0.001), and IL­2 was lower by 56.08% 
(р<0.001), IL­4 – by 39.66% (p<0.001), IL­6 – by 
34.67% (p<0.01), and compared with the 
previous period, IL­1beta was increased by 
22.06% (р<0.001), IL­10 – in 2.547 times 
(p<0.001), IL­2 was decreased by 83.20% 
(p<0.02), IL­6 – by 33.38% (p<0.001), IL­4 – by 
6.26% (p<0.001).
In 7 days compared to the control the 
increase of TNF­alpha in 17.88 times (p<0.001) 
was observed, as well as the decrease of IL­1 
beta by 45.81% (p<0.001), IL­2 – by 47.97% 
(p<0.001), IL­4 – by 20.54% (p<0.001), and 
compared with the previous period of study, 
IL­1beta was decreased by 55.57% (p<0.001), 
IL­10 – by 16.57% (p<0.001), IL­6 was increased 
by 70.81% (p<0.01), TNF­alpha – in 2.53 times 
(p<0.001), IL­4 – by 31.69% (p<0.001).
In 14 days compared to the control the in­
crease of TNF­alpha in 19.69 times (p<0.001) was 
evidenced, as well as the decrease of IL­1 beta by 
40.45% (p<0.001), IL­2 – by 37.84% (p<0.001), IL­4 – 
by 21.08% (p<0.001), IL­10 – by 39.67% (p<0.002), 
and compared with the previous study period – 
the decrease of IL­10 by 47.28% (p<0.001).
In 21 days compared with the control, the 
increase of TNF­alpha in 2.1 times (p<0.001), 
IL­6 – by 72.91% (p<0.001), the decrease of IL­4 
by 28.06% (p<0.001), IL­2 – by 22.30% (p<0.02), 
and compared with a previous period of study – 
the decrease of TNF­alpha by 89.87% (p<0.001), 
increase of IL­6 by 70.73% (p<0.001) and IL­10 – 
by 78.85% (p<0.001) were present.
In 28 days the increase of TNF­alpha in 25.89 
times (p<0.001), IL­6 – by 36.94% (p<0.02), the 
decrease of IL­1 beta by 45.38% (p<0.001), IL­2 – 
by 35.13% (p<0.001), IL­4 – by 19.52% (p<0.001), 
and compared to the previous period of study, 
the increase in TNF­alpha in 11.87 times 
(p<0.001), and the decrease of IL­1beta by 
39.43% (p<0.05) were evidenced.
Injections of quercetin for 7 days caused a 
significant decrease of IL­2 by 62.84% (p<0.001), 
IL­4 – by 32.32% (p<0.001), IL­10 – by 51.92% 
(p<0.001), and increase of IL­6 in 2.7 times 
(p<0.001).
In 7 days after the injury, quercetin 
correction proved increased level of IL­1beta in 
2.61 times (p<0.001), IL­4 – by 35% (p<0.001), 
IL­6 – in 2.27 times (p<0.001), and decrease of 
TNF­alpha in 32.99 times (p<0.001). In this 
period, IL­2, IL­4, IL­10 levels did not significantly 
differ from the control ones, and IL­1beta was 
increased by 41.6% (p<0.001), IL­2 – by 29.73% 
(p<0.001), IL­6 – in 2.54 times (p<0.001). IL­1 
beta level was also higher by 60% (p<0.01), TNF­ 
alpha – in 9.26 times (p<0.001), IL­4 – by 58.5% 
(p<0.002), IL­10 – in 2.69 times (p<0.001) 
compared to the quercetin level.
In 14 days after the injury, the quercetin 
correction proved higher level of TNF­alpha by 
55.14% (p<0.01) and IL­10 by 84.76% (p<0.001). 
In this period, only IL­10 level did not significantly 
differ from the control ones, IL­6 was increased 
by 49.59% (p<0.05), TNF­alpha – in 32.1 times 
(p<0.001), IL­1beta was decreased by 28.5% 
(p<0.01), IL­2 – by 28.38% (p<0.001), IL­4 – by 
23.7% (p<0.001), and compared to a previous 
period of study IL­1 beta was decreased by 
49.5% (p<0.001), IL­6 – by 40.97% (p<0.002), and 
IL­4 – by 28.87% (p<0.05), TNF­alpha was 
increased in 2.68 times (p<0.001). IL­2 was also 
higher in 1.93 times (p<0.001), TNF­alpha – in 
24.8 times (p<0.001), IL­10 – in 2.32 times 
(p<0.001) and IL­6 was lower by 44.7% (p<0.01) 
compared to the quercetin level.
In 21 days after the injury, the quercetin 
correction proved higher level of H­6 by 51.42% 
(p<0.002), TNF­alpha in 9.59 times (p<0.001), 
lower level of H­2 by 50.43% (p<0.001). In this 
period, only IL­1 beta level did not significantly 
differ from the control, H­6 was higher in 2.62 
times (p<0.001), TNF­alpha – in 20.1 times 
(p<0.001), IL­10 – by 20.07% (p<0.001), IL­2 was 
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lower by 61.49% (p<0.001), IL­4 – by 36.5% 
(p<0.001), and compared with a previous period 
of study the decrease of IL­2 by 46.23% (p<0.001), 
TNF­alpha – by 37.4% (p<0.001), IL­4 – by 16.77% 
(p<0.05), the increase of IL­6 by 74.91% (p<0.002) 
were present. TNF­alpha was also higher in 15.53 
times (p<0.001) and IL­10 – in 2.5 times (p<0.001) 
compared to the quercetin level.
In 28 days after the injury, the quercetin 
correction proved higher level of IL­1 beta in 
2.26 times (p<0.001), lower level of TNF­alpha 
by 64.38% (p<0.01). In this period, only IL­10 did 
not significantly differ from the control level, 
IL­1 beta was higher by 23.28% (p<0.001), IL­6 – 
by 65.62% (p<0.001), TNF­alpha – in 8.87 times 
(p<0.01), IL­2 was lower by 41.89% (p<0.001), 
IL­4 – by 27.48% (p<0.001), and compared with 
a previous period of study the decrease of IL­6 
by 36.74% (p<0.002), TNF­alpha by 55.88% 
(p<0.001), IL­10 by 19.68% (p<0.001), the 
increase of IL­1 beta by 34.04% (p<0.001), IL­2 
by 50.88% (p<0.001), IL­4 by 14.19% (p<0.05) 
were present. IL­2 level was also higher by 
56.36% (p<0.001), TNF­alpha – in 6.85 times 
(p<0.05) IL­10 – in 2 times (p<0.001), and IL­6 
was lower by 38.82% (p<0.05) compared to the 
quercetin level.
Discussion
In first hour a direct damage of heart muscle 
by adrenaline was present, since the рroinflam­
matory cytokine TNF­alpha was a mediator of 
cardiac pathology. TNF­alpha was synthesized 
by activated macrophages, and also stimulated 
them, promoted cytotoxic, immunomodulating, 
anti­inflammatory action. Decreases in IL­10 and 
IL­4 may be associated with the early period of 
damaging effects of adrenaline and calcium 
when the increase of one anti­inflammatory 
cytokine was sufficient with protection.
In two hours a high TNF­alpha content still 
was present. It could cause damage to endothelial 
cells, increase of microvascular permeability, 
activate the hemostasis system with DIC synd­
rome development. Normalizing the concen tra­
tion of IL­4 and IL­10 may evidence development 
of immune response with involvement of T­ and 
B­lymphocytes. That was evidenced by the 
increase of IL­1beta. The decrease of IL­2 and 
IL­6 proved immunosuppressive effect.
In day 1 high values of TNF­alpha and IL­6, 
in the presence of decreased IL­4, may evidence 
the activation of coagulation hemostasis with 
the development of blood clots. The increase 
of IL­6 also evidenced development of hypoxia, 
which may take place due to necrosis of cardio­
myocytes.
The increase of IL­1beta and TNF­alpha in 
day 3 could be caused by more severe hypoxia 
and ischemia, products of fibrin degradation. 
The increase of IL­10 proved its protective 
influence. in day 7, compared to the previous 
period, IL­6 normalization may evidence the 
worsening of hypoxia. TNF­alpha increase and 
decrease of H­10 only confirmed this assertion. 
That was observed in 14 days also.
In 21 and 28 days the same changes as in a 
24 hour period were present: high level of TNF­ 
alpha and IL­6 in the presence of decreased 
IL­4. It may prove the secondary activation of 
coagulation hemostasis by means of alteration.
In the infarcted myocardium, necrotic 
cardiomyocytes release danger signals activating 
an intense inflammatory reaction that serves to 
clear the wound from dead cells and matrix 
debris, but may also extend injury. Dead 
cardiomyocytes release IL­1α that may function 
as a crucial alarm in triggering the post­in­
farction inflammatory reaction. IL­1β is markedly 
up­regulated in the infarcted myocardium; 
activation of inflammasome in both cardio­
myocytes and interstitial cells results in release 
of bioactive IL­ip in the infarcted area. Binding 
of IL­1 to the type 1 receptor triggers an in­
flammatory cascade, inducing recruitment of 
proinflammatory leukocytes and stimulating a 
matrix­degrading program in fibroblasts, while 
delaying myofibroblast conversion. IL­1 mediates 
dilative remodeling following infarction and may 
influence on the pathogenesis of postinfarction 
heart failure [7].
Injection of quercetin in the experiments 
increased contents of IL­6, suppressing the 
formation of IL­2, IL­4 and IL­10. Adrenaline and 
calcium lesion of heart in which quercetin was 
used had a favorable course. Thus, in 7 days, 
the decreased activation of TNF­alpha was 
observed, and increased – of IL­4, IL­6, and IL­1 
beta. In 14 days, the increased activation of TNF­
alpha, normalization of H­10 to the control level 
was evidenced. The increased content of IL­6, 
decreased – of IL­1 beta, IL­2, IL­4 were present. 
In 21 days, the increased content of TNF­alpha, 
IL­6 was evidenced. IL­10 level did not differ from 
the control, IL­2 content was decreased. In 28 
days, the increased activation of IL­1beta, 
decreased content of TNF­alpha was observed.
IL­10 improved myocardial function after 
acute global I/R and suppressed inflammation 
of STAT3 pathway [8]. Also the profibrotic effect 
of IL­10 autocrine loop promoted macrophages 
to secret osteopontin and TGFp. These media­
tors activated cardiac fibroblasts to produce 
collagen that caused cardiac fibrosis and in crea­
sed cardiac stiffness [9]. Increased IL­6 con tent 
was associated with a cardiovascular disease 
and protected cells against apoptosis whilst 
being important for normal metabolism [10]. 
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The obtained data has proved the inclusion 
of pro­ and anti­inflammatory mechanisms of 
protection against damage, when used with the 
protective effect of quercetin. Quercetin in 
cases of more severe fibrosis with underlying 
injury of ACM of rats prevents cardiac necrosis.
Conclusions
The development of adrenaline­calcium 
heart damage is accompanied by bright cytokine 
wavelike reaction at different time points. In 
early time a direct damage of heart muscle by 
adrenaline and calcium is present. Then can be 
development of DIC syndrome, immune res­
ponse, hypoxia, and ischemia. At day 3 increases 
the protective influence – anti­inflammatory 
interleukins level. Then evidence the worsening 
of hypoxia, secondary activation of coagulation 
hemostasis by means of alteration. Quercetin 
causes normalization of interleukins level.
ЗМІНИ ПРОЗАПАЛЬНИХ ТА ПРОТИЗАПАЛЬНИХ ЦИТОКИНІВ  
НА МОДЕЛІ АДРЕНАЛІНОВО-КАЛЬЦІЄВОГО УРАЖЕННЯ МІОКАРДА 
У ЩУРІВ ТА КОРЕКЦІЇ КВЕРЦЕТИНОМ 
О. В. Денефіль, А. М. Мусієнко
ТЕРНОПІЛЬСЬКИЙ ДЕРЖАВНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ ІМЕНІ І. Я. ГОРБАЧЕВСЬКОГО, ТЕРНОПІЛЬ, УКРАЇНА
Вступ. Серцева недостатність є однією з основних причин захворюваності та смертності у світі.
Метою дослідження було визначення коливань інтерлейкінів на моделі адреналіново-кальцієвого ураження 
міокарда та його корекції кверцетином. 
Методи. Досліди проведені на 143 щурах-самцях лінії Вістар віком 5-6 місяців. Було досліджено зміни вмісту 
інтерлейкінів IL-1beta, IL-2, IL-4, IL-6, IL-10, TNF-альфа у сироватці крові при розвитку ураження серця  та застосування 
кверцетину. Дослідження  проводили у 1-у, 2-у, 24-у години, на 3-ю, 7-у, 14-у, 21-у та 28-у доби.
Результати. Адреналіно-кальцієва модель ураження міокарда характеризувалася підвищенням рівня TNF-альфа; 
а вміст IL-2 та IL-4 поступово достовірно знижувався. Рівень IL-1бета зростав на 2-у і 3-ю доби після формування 
ураження серцевого м’яза, у інших періодах часу досліджень (за винятком 1 години і 21-ї доби) ці показники знижувалися. 
Спостерігалися також хвилеподібні коливання вмісту IL-6 і IL-10.
Ін’єкції кверцетину протягом 7 днів зумовили достовірне зниження IL-2, IL-4, IL-10 та підвищення вмісту IL-6. 
Також спостерігалося зниження рівня TNF-альфа, та підвищення вмісту IL-4, IL-6 та IL-1. Через 14 днів все ще 
спостерігалося підвищення рівня TNF-альфа та нормалізація показників IL-10. На 28-у добу зафіксовано підвищений 
вміст IL-1beta та зниження рівня TNF-альфа.
Висновки. Розвиток адреналіно-кальцієвого ураження серця супроводжується яскравою хвилеподібною реакцією 
цитокінів у різні досліджувані проміжки часу  час. Кверцетин викликає нормалізацію рівня інтерлейкінів.
КЛЮЧОВІ СЛОВА: адреналіново-кальцієва модель ураження міокарду; щури; кверцетин; інтерлейкіни.
